N-(2-Methyl-4-oxopentan-2-yl)acrylamide, 95.0%, 1kg

3-Bromo-4'-chloro-1,1'-biphenyl>97.0%(GC)5g

5-Methyl-1,2,3,4-tetrahydroquinoxaline, 250mg

Ethyl 2-((4-methoxyphenyl)amino)-2-oxoacetate, 95+%, 25g

2-Chloro-6-ethoxypyridin-4-amine, 95+%, 100mg

Mounting Solution (RI 1.520) [for CUBIC-R+]50mL

6-Bromo-2-chloroquinolin-5-amine, 98%, 250mg

Centrifuge filter unit Ultrafree Ultrafree-MC, PVDF membrane, sample volume up to 0.5 ml, 0,10 µm, Non-sterile, 25 Piece(s)

30 ml medicine bottle glass brown PP 28 round

5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide, 97.0%, 1g

3-(2-Bromophenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine, 95.0%, 1g

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carboxylate, 97%, 100mg

Platinum AAS standard solution, ROTI®Star, 500 ml, glass packaging